This smaller biotech company attracted a lot of attention in 2020, but is it still worth an investment? The post Moderna’s stock has surged 488%
Trade The World Anywhere & Anytime!
Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.
Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.
- Analysts rate these ASX 200 shares as buys
- Analysts are tipping huge gains for these small cap ASX shares
- 2 fast growth ASX shares that could be buys in December 2021
- Hold the phone! Why Telstra (ASX:TLS) could be a dividend share to buy
- Could this be a fly in the appointment for Woolworths’ (ASX:WOW) push into healthcare?